Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
News
Menu
Corneal implant
ReVision Optics is set to perform an evaluation of the tiny implantable lens on 400 subjects over the course of the three-year FDA trial. Credits: iStockphoto/RVO.
Copyright © 2021 SPIE EuropeDesigned by Kestrel Web Services